The largest database of trusted experimental protocols

Pvdf membrane based syringe filter unit

Manufactured by Merck Group
Sourced in United States

The PVDF membrane-based syringe filter unit is a laboratory equipment designed for the filtration of liquid samples. The PVDF (polyvinylidene fluoride) membrane acts as the filtration medium, allowing for the removal of particulates, microorganisms, and other contaminants from the sample. The syringe filter unit is a self-contained, easy-to-use device that can be easily integrated into various laboratory workflows.

Automatically generated - may contain errors

2 protocols using pvdf membrane based syringe filter unit

1

In Vitro Ovalbumin Release Kinetics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Directly after antigen loading, the OVA-encapsulated microspheres (~20 mg) were rinsed with ddH2O, as described above, to remove any unencapsulated OVA. The microspheres were then immediately resuspended in 0.5 mL of PBS, pH 7.4, and incubated at 37 °C under constant agitation (240 rpm/min). At different incubation times (1, 3, 5, and 7 days, and then every 7 days until day 49), the mixture was centrifuged at 7000 rpm for 5 min, and the supernatant was collected through a low protein-binding Durapore (PVDF) membrane-based syringe filter unit (Millipore Corporation, USA). Fresh PBS release media (0.5 mL) was then added to the sample, and the microspheres were resuspended to continue the release study. The OVA content in the supernatants was analyzed by SE-HPLC.
+ Open protocol
+ Expand
2

Quantifying OVA Encapsulation in Microspheres

Check if the same lab product or an alternative is used in the 5 most similar protocols
After self-encapsulation of the protein, the microsphere samples were centrifuged at 7000 rpm for 5 min. The supernatant was passed through a low protein-binding Durapore (PVDF) membrane-based syringe filter unit (Millipore Corporation, USA) and the filtrate collected. The microspheres were then washed once with ddH2O and the rinse filtered and collected. A modified Bradford assay was used to determine OVA concentration in the filtrates. Coomassie Plus reagent (Thermo Fisher Scientific, USA) was added to the appropriate volume of standard OVA solution or filtrate sample in a 96-well plate (Nunc, Thermo Scientific, USA). After 10 min, the absorbance was read at 595 nm using a Dynex II MRX microplate reader (Dynex Technology Inc., USA). The mass of OVA encapsulated by the microspheres was calculated by subtracting the mass of OVA in the filtrates from the mass of OVA in the initial loading solution. Percent w/w loading and encapsulation efficiency (EE) were quantified with the following formulas:
%w/w loading=mass of OVA encapsulated by the microspheresmass of microspheres in loading sample+mass of OVA encapsulated×100%EE=mass of OVA encapsulated by the microspheresmass of OVA in initial loading solution×100
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!